Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis

Peer Review reports

Original Submission
22 Apr 2013	Submitted	Original manuscript
24 Apr 2013	Author responded	Author comments - Tomas Buchler
Resubmission - Version 2
24 Apr 2013	Submitted	Manuscript version 2
30 Jan 2014	Reviewed	Reviewer Report - Bruce Giantonio
11 Feb 2014	Reviewed	Reviewer Report - Pilar García-Alfonso
11 Mar 2014	Author responded	Author comments - Tomas Buchler
Resubmission - Version 3
11 Mar 2014	Submitted	Manuscript version 3
27 Apr 2014	Author responded	Author comments - Tomas Buchler
Resubmission - Version 4
27 Apr 2014	Submitted	Manuscript version 4
Publishing
30 Apr 2014	Editorially accepted
7 May 2014	Article published	10.1186/1471-2407-14-323

Back to article page